CYP51/PD-L1-IN-2
CYP51/PD-L1-IN-2 (compound L20) is a quinazoline compound with antifungal activity. CYP51/PD-L1-IN-2 is a dual inhibitor of CYP51 (IC50: 0.263 μM) and PD-L1 (IC50: 0.017 μM), which can induce early apoptosis of fungal cells in the cell cycle. CYP51/PD-L1-IN-2 also significantly reduced intracellular IL-2, NLRP3, and NF-κBp65 protein levels, induced mitochondrial damage and ROS accumulation, and ultimately led to fungal lysis and death[1].
Product Specifications
CAS Number
3032386-58-3
UNSPSC
12352005
Target
Cytochrome P450; Fungal; PD-1/PD-L1
Type
Reference compound
Related Pathways
Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cyp51-pd-l1-in-2.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=NC2=CC=CC=C2C(N3C=NC=N3)=N1)NC4CCN(C(C5=CC=C(C(C)=O)C=C5)=O)CC4
Molecular Formula
C25H23N7O3
Molecular Weight
469.50
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Histone H1 (AE-4), CF640R conjugate, 0.1mg/mL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF640R conjugate, 0.1mg/mL
TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), CF647 conjugate, 0.1mg/mL
Human IgG Immunoglobulin (B33/20), CF740 conjugate, 0.1mg/mL
